Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-10-22-Speech-2-045"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medicinal products2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20021022.1.2-045"2
lpv:hasSubsequent	lp_eu:2002-10-22-Speech-2-0472
lpv:speaker	lp:Nicole Thomas-mauro2
lpv:spokenAs	unknown; Mouvement pour la France (2000-11-23--2003-06-16)3 substitute; EMPL (2002-01-17--2003-03-10)3 member; NA (2001-01-31--2003-03-10)3 member; Committee on Women's Rights and Equal Opportunities (2002-01-17--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 member; Delegation to the EU-Lithuania Joint Parliamentary Committee (2002-02-07--2004-04-30)3 substitute; Delegation to the EU-Hungary Joint Parliamentary Committee (2002-02-06--2003-03-10)3
lpv:translated text	". It is a fact, the policy on medical products is now defined at European level. This development must be supported without jeopardising the operation of the national health systems and whilst respecting the need for maximum safety. With regard to medicinal products for human use, Amendment No 71, which I tabled, fully supports this approach. It aims to learn lessons from the tragic ‘Bayer affair’ at the very time when the problems posed by the molecule cerivastatin have been raised once again in the United States. We must reflect on the need to standardise the procedures that apply to clinical and pre-clinical trials. If the traceability of the marketing procedure were better assured, the safety of European patients would become more reliable. A credible application of the centralised procedure for marketing medicinal products cannot work without this sort of approach. I am opposed, however, to the full withdrawal of the decentralised procedure to the exclusive benefit of the centralised marketing procedure. The choice between these two systems must be maintained so that the European Agency does not remove the prerogatives of our national agencies."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph